U.S. Dialysis Centers Market Size, Share & Trends Analysis Report By Modality (In-center, In-home, SNF-based), By Dialysis Type (Hemodialysis, Peritoneal Dialysis), By Facility Type, By Region, And Segment Forecasts, 2023 - 2030
This report can be delivered to the clients within 6 Business Days
U.S. Dialysis Centers Market Growth & Trends
The U.S. dialysis centers market size is expected to reach USD 40.4 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.29% from 2023 to 2030. The high prevalence of End-Stage Renal Disease (ESRD) and favorable reimbursement are some of the key factors expected to boost growth. The expenditure on treatment is gradually rising due to the increasing prevalence of ESRD.
The availability of Medicare reimbursement for kidney disorder treatment is increasing the accessibility to the treatment. The Center for Medicare & Medicaid Services announced a new end-stage renal diseases treatment choice model for the maintenance & improvement in the reimbursement for chronic kidney disorder patients. The new model is encouraging the use of home-based treatment. In August 2022, the CMS expanded the eligibility for reimbursement for kidney disorder treatment. The expansion includes certain capital assets, mainly equipment used at home for treatment. This is increasing the accessibility to the services.
The patients need to travel to and fro the center for around 3 days per week, the proximity from the patient's residence is generally an important criterion for the center of choice. Hence the launch of new facilities is a key strategic initiative undertaken by major players to increase their market share. For instance, in May 2021, U.S. Renal Care, Inc. inaugurated three new facilities, one in-center facility and two focusing on home therapies. This expanded the company’s presence in the Southwest Florida region.
The COVID-19 pandemic resulted in patients facing difficulty in having an access to treatment for end-stage renal disorder, requiring multiple sessions within a month. According to the national kidney foundation, 15.8% of the patients undergoing treatment for end-stage renal disease had COVID-19 infection. The federal government & service providers promoted home treatment. In June 2021, a new campaign innovative kidney care was launched by nine leading healthcare organizations for patient options for receiving home treatment.
U.S. Dialysis Centers Market Report Highlights
U.S. Dialysis Centers Market Growth & Trends
The U.S. dialysis centers market size is expected to reach USD 40.4 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.29% from 2023 to 2030. The high prevalence of End-Stage Renal Disease (ESRD) and favorable reimbursement are some of the key factors expected to boost growth. The expenditure on treatment is gradually rising due to the increasing prevalence of ESRD.
The availability of Medicare reimbursement for kidney disorder treatment is increasing the accessibility to the treatment. The Center for Medicare & Medicaid Services announced a new end-stage renal diseases treatment choice model for the maintenance & improvement in the reimbursement for chronic kidney disorder patients. The new model is encouraging the use of home-based treatment. In August 2022, the CMS expanded the eligibility for reimbursement for kidney disorder treatment. The expansion includes certain capital assets, mainly equipment used at home for treatment. This is increasing the accessibility to the services.
The patients need to travel to and fro the center for around 3 days per week, the proximity from the patient's residence is generally an important criterion for the center of choice. Hence the launch of new facilities is a key strategic initiative undertaken by major players to increase their market share. For instance, in May 2021, U.S. Renal Care, Inc. inaugurated three new facilities, one in-center facility and two focusing on home therapies. This expanded the company’s presence in the Southwest Florida region.
The COVID-19 pandemic resulted in patients facing difficulty in having an access to treatment for end-stage renal disorder, requiring multiple sessions within a month. According to the national kidney foundation, 15.8% of the patients undergoing treatment for end-stage renal disease had COVID-19 infection. The federal government & service providers promoted home treatment. In June 2021, a new campaign innovative kidney care was launched by nine leading healthcare organizations for patient options for receiving home treatment.
U.S. Dialysis Centers Market Report Highlights
- Based on service, the in-center segment held the largest revenue share in 2022. This can be attributed to the need for assistance & care for the procedure, which can be facilitated better at the centers. The high preference for hemodialysis is also driving the market opportunity as it essentially requires center visits & assistance
- Based on dialysis type, hemodialysis dominated the market in 2022. This can be attributed to the preference for the segment by healthcare professionals & longer life expectancy for patients. However peritoneal dialysis is expected to have the fastest growth during the forecast period owing to the effective removal of toxic substances & high convenience of peritoneal dialysis enabling patients to independently have treatment at home
- Based on facility type, dialysis chains dominated the market in 2022. This can be attributed to the presence of such chains throughout the U.S. The availability of top-quality equipment and treatment at a lower cost compared to hospital-based facilities is driving the segment’s growth. In addition, the key players are acquiring independent facilities, resulting in most of the independent facilities being managed by chains
- Based on the region, the southeast region accounted for a significant revenue share in 2022 owing to the better accessibility to treatment and a higher elder population in the region. Florida & Georgia are among the states having the highest geriatric population in the U.S. as per the U.S. census bureau 2020 estimates
- The service providers and patients faced challenges since the onset of the COVID-19 pandemic, some of which are unique as compared to other health facilities and treatment groups. For instance, hemodialysis (HD) patients visit centers at least three times a week and during each session, the patients are exposed to all the patients concurrently receiving treatment in a particular session, and to healthcare personnel along with any additional exposure during their travel to and from the center
- Mergers & acquisitions and collaborations are being preferred by the key players, enabling them to have a competitive edge by adding value to their services. For Instance, in March 2022, Fresenius Medical Care announced a merger with InterWell Health and Cricket Health for facilitating better kidney disorder solutions
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Model Details
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective -
1.9.2 Objective -
1.9.3 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Modality
2.2.2 Dialysis Type
2.2.3 Facility Type
2.2.4 Region
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 High prevalence of renal diseases
3.3.1.2 Technological advancements in dialysis
3.3.2 Market restraint analysis
3.3.2.1 Challenges in providing quality care
3.3.2.2 Complications associated with dialysis
3.4 U.S. Dialysis Centers Industry Analysis - Porter’s
3.4.1 Bargaining power of buyers: moderate
3.4.2 Bargaining power of suppliers: high
3.4.3 Competitive rivalry: moderate
3.4.4 Threat of new entrants: low
3.4.5 Threat of substitutes: low
3.5 Regulatory & Reimbursement Scenario
3.6 Qualitative Analysis: Impact of COVID-19 on the U.S. Dialysis Centers Market
CHAPTER 4 U.S. DIALYSIS CENTERS MARKET: MODALITY ANALYSIS
4.1 U.S. Dialysis Centers Modality Market Share Analysis, 2022 & 2030
4.2 U.S. Dialysis Centers Modality Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, Modality Segment, 2017 to 2030
4.3.1 In-Center
4.3.1.1 In-center market, 2017 - 2030 (USD Billion)
4.3.2 In-Home
4.3.2.1 In-home market, 2017 - 2030 (USD Billion)
4.3.3 SNF-based
4.3.3.1 SNF-based market, 2017 - 2030 (USD Billion)
CHAPTER 5 U.S. DIALYSIS CENTERS MARKET: DIALYSIS TYPE ANALYSIS
5.1 U.S. Dialysis Centers Dialysis Type Market Share Analysis, 2022 & 2030
5.2 U.S. Dialysis Centers Dialysis Type Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, Dialysis Type Segment, 2017 to 2030
5.3.1 Hemodialysis
5.3.1.1 Hemodialysis market, 2017 - 2030 (USD Billion)
5.3.2 Peritoneal dialysis
5.3.2.1 Peritoneal dialysis market, 2017 - 2030 (USD Billion)
CHAPTER 6 U.S. DIALYSIS CENTERS MARKET: FACILITY TYPE ANALYSIS
6.1 U.S. Dialysis Centers Facility Type Market Share Analysis, 2022 & 2030
6.2 U.S. Dialysis Centers Facility Type Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, Facility Segment, 2017 to 2030
6.3.1 Dialysis Chains
6.3.1.1 Dialysis chains market, 2017 - 2030 (USD Billion)
6.3.2 Independent Facilities
6.3.2.1 Independent facilities market, 2017 - 2030 (USD Billion)
6.4.2 Hospital-based
6.4.2.1 Hospital-based market, 2017 - 2030 (USD Billion)
CHAPTER 7 U.S. DIALYSIS CENTERS MARKET: REGION ANALYSIS
7.1 U.S. Dialysis Centers Region Market Share Analysis, 2022 & 2030
7.2 Region Dashboard
7.3 Market Size & Forecasts and Trend Analysis, 2017 to 2030 for Region
7.3.1 Northeast
7.3.1.1 Northeast market, 2017 - 2030 (USD Billion)
7.3.2 Southeast
7.3.2.1 Southeast market, 2017 - 2030 (USD Billion)
7.3.3 Southwest
7.3.3.1 Southwest market, 2017 - 2030 (USD Billion)
7.3.4 Midwest
7.3.4.1 Midwest market, 2017 - 2030 (USD Billion)
7.3.4 West
7.3.4.1 West market, 2017 - 2030 (USD Billion)
CHAPTER 8 COMPETITIVE ANALYSIS
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
8.3 Company Market Position Analysis
8.4 Company Profiles
8.4.1 Fresenius Medical Care AG & Co. KGaA
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Service benchmarking
8.4.1.4 Strategic initiatives
8.4.2 U.S. Renal Care, Inc.
8.4.2.1 Company overview
8.4.2.2 Service benchmarking
8.4.2.3 Strategic initiatives
8.4.3 DaVita Inc.
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Service benchmarking
8.4.3.4 Strategic initiatives
8.4.4 American Renal Associates
8.4.4.1 Company overview
8.4.4.2 Service benchmarking
8.4.4.3 Strategic initiatives
8.4.5 Dialysis Clinic, Inc.
8.4.5.1 Company overview
8.4.5.2 Service benchmarking
8.4.6 Satellite Healthcare
8.4.6.1 Company overview
8.4.6.2 Service benchmarking
8.4.6.3 Strategic initiatives
8.4.7 Northwest Kidney Centers
8.4.7.1 Company overview
8.4.7.2 Service benchmarking
8.4.7.3 Strategic initiatives
8.4.8 Centers for Dialysis Care
8.4.8.1 Company overview
8.4.8.2 Service benchmarking
8.4.8.3 Strategic initiatives
8.4.9 Rogosin Institute
8.4.9.1 Company overview
8.4.9.2 Service benchmarking
8.4.10 Dialysis Care Center
8.4.10.1 Company overview
8.4.10.2 Service benchmarking
8.4.10.3 Strategic initiatives
8.4.11 UCSF Health
8.4.11.1 Company overview
8.4.11.2 Financial performance
8.4.11.3 Service benchmarking
8.4.11.4 Strategic initiatives
8.4.12 Rhode Island Hospital
8.4.12.1 Company overview
8.4.12.2 Financial performance
8.4.12.3 Service benchmarking
8.4.12.4 Strategic initiatives
8.4.13 University of Iowa Hospital & Clinics
8.4.13.1 Company overview
8.4.13.2 Financial performance
8.4.13.3 Service benchmarking
8.4.13.4 Strategic initiatives
8.4.14 Saint Anthony Hospital
8.4.14.1 Company overview
8.4.14.2 Financial performance
8.4.14.3 Service benchmarking
8.4.14.4 Strategic initiatives
8.4.15 Rush Unit Children’s Hospital
8.4.15.1 Company overview
8.4.15.2 Financial performance
8.4.15.3 Service benchmarking
8.4.15.4 Strategic initiatives
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Model Details
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective -
1.9.2 Objective -
1.9.3 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Modality
2.2.2 Dialysis Type
2.2.3 Facility Type
2.2.4 Region
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 High prevalence of renal diseases
3.3.1.2 Technological advancements in dialysis
3.3.2 Market restraint analysis
3.3.2.1 Challenges in providing quality care
3.3.2.2 Complications associated with dialysis
3.4 U.S. Dialysis Centers Industry Analysis - Porter’s
3.4.1 Bargaining power of buyers: moderate
3.4.2 Bargaining power of suppliers: high
3.4.3 Competitive rivalry: moderate
3.4.4 Threat of new entrants: low
3.4.5 Threat of substitutes: low
3.5 Regulatory & Reimbursement Scenario
3.6 Qualitative Analysis: Impact of COVID-19 on the U.S. Dialysis Centers Market
CHAPTER 4 U.S. DIALYSIS CENTERS MARKET: MODALITY ANALYSIS
4.1 U.S. Dialysis Centers Modality Market Share Analysis, 2022 & 2030
4.2 U.S. Dialysis Centers Modality Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, Modality Segment, 2017 to 2030
4.3.1 In-Center
4.3.1.1 In-center market, 2017 - 2030 (USD Billion)
4.3.2 In-Home
4.3.2.1 In-home market, 2017 - 2030 (USD Billion)
4.3.3 SNF-based
4.3.3.1 SNF-based market, 2017 - 2030 (USD Billion)
CHAPTER 5 U.S. DIALYSIS CENTERS MARKET: DIALYSIS TYPE ANALYSIS
5.1 U.S. Dialysis Centers Dialysis Type Market Share Analysis, 2022 & 2030
5.2 U.S. Dialysis Centers Dialysis Type Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, Dialysis Type Segment, 2017 to 2030
5.3.1 Hemodialysis
5.3.1.1 Hemodialysis market, 2017 - 2030 (USD Billion)
5.3.2 Peritoneal dialysis
5.3.2.1 Peritoneal dialysis market, 2017 - 2030 (USD Billion)
CHAPTER 6 U.S. DIALYSIS CENTERS MARKET: FACILITY TYPE ANALYSIS
6.1 U.S. Dialysis Centers Facility Type Market Share Analysis, 2022 & 2030
6.2 U.S. Dialysis Centers Facility Type Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, Facility Segment, 2017 to 2030
6.3.1 Dialysis Chains
6.3.1.1 Dialysis chains market, 2017 - 2030 (USD Billion)
6.3.2 Independent Facilities
6.3.2.1 Independent facilities market, 2017 - 2030 (USD Billion)
6.4.2 Hospital-based
6.4.2.1 Hospital-based market, 2017 - 2030 (USD Billion)
CHAPTER 7 U.S. DIALYSIS CENTERS MARKET: REGION ANALYSIS
7.1 U.S. Dialysis Centers Region Market Share Analysis, 2022 & 2030
7.2 Region Dashboard
7.3 Market Size & Forecasts and Trend Analysis, 2017 to 2030 for Region
7.3.1 Northeast
7.3.1.1 Northeast market, 2017 - 2030 (USD Billion)
7.3.2 Southeast
7.3.2.1 Southeast market, 2017 - 2030 (USD Billion)
7.3.3 Southwest
7.3.3.1 Southwest market, 2017 - 2030 (USD Billion)
7.3.4 Midwest
7.3.4.1 Midwest market, 2017 - 2030 (USD Billion)
7.3.4 West
7.3.4.1 West market, 2017 - 2030 (USD Billion)
CHAPTER 8 COMPETITIVE ANALYSIS
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
8.3 Company Market Position Analysis
8.4 Company Profiles
8.4.1 Fresenius Medical Care AG & Co. KGaA
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Service benchmarking
8.4.1.4 Strategic initiatives
8.4.2 U.S. Renal Care, Inc.
8.4.2.1 Company overview
8.4.2.2 Service benchmarking
8.4.2.3 Strategic initiatives
8.4.3 DaVita Inc.
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Service benchmarking
8.4.3.4 Strategic initiatives
8.4.4 American Renal Associates
8.4.4.1 Company overview
8.4.4.2 Service benchmarking
8.4.4.3 Strategic initiatives
8.4.5 Dialysis Clinic, Inc.
8.4.5.1 Company overview
8.4.5.2 Service benchmarking
8.4.6 Satellite Healthcare
8.4.6.1 Company overview
8.4.6.2 Service benchmarking
8.4.6.3 Strategic initiatives
8.4.7 Northwest Kidney Centers
8.4.7.1 Company overview
8.4.7.2 Service benchmarking
8.4.7.3 Strategic initiatives
8.4.8 Centers for Dialysis Care
8.4.8.1 Company overview
8.4.8.2 Service benchmarking
8.4.8.3 Strategic initiatives
8.4.9 Rogosin Institute
8.4.9.1 Company overview
8.4.9.2 Service benchmarking
8.4.10 Dialysis Care Center
8.4.10.1 Company overview
8.4.10.2 Service benchmarking
8.4.10.3 Strategic initiatives
8.4.11 UCSF Health
8.4.11.1 Company overview
8.4.11.2 Financial performance
8.4.11.3 Service benchmarking
8.4.11.4 Strategic initiatives
8.4.12 Rhode Island Hospital
8.4.12.1 Company overview
8.4.12.2 Financial performance
8.4.12.3 Service benchmarking
8.4.12.4 Strategic initiatives
8.4.13 University of Iowa Hospital & Clinics
8.4.13.1 Company overview
8.4.13.2 Financial performance
8.4.13.3 Service benchmarking
8.4.13.4 Strategic initiatives
8.4.14 Saint Anthony Hospital
8.4.14.1 Company overview
8.4.14.2 Financial performance
8.4.14.3 Service benchmarking
8.4.14.4 Strategic initiatives
8.4.15 Rush Unit Children’s Hospital
8.4.15.1 Company overview
8.4.15.2 Financial performance
8.4.15.3 Service benchmarking
8.4.15.4 Strategic initiatives
LIST OF TABLES
TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 U.S.dialysis center market estimates and forecast, by modality, 2017 - 2030 (USD Billion)
TABLE 4 U.S.dialysis center dialysis type market estimates and forecast, by dialysis type 2017 - 2030 (USD Billion)
TABLE 5 U.S.dialysis center modality market estimates and forecast, by facility type 2017 - 2030 (USD Billion)
TABLE 6 U.S.dialysis center dialysis type market estimates and forecast, by region 2017 - 2030 (USD Billion)
TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 U.S.dialysis center market estimates and forecast, by modality, 2017 - 2030 (USD Billion)
TABLE 4 U.S.dialysis center dialysis type market estimates and forecast, by dialysis type 2017 - 2030 (USD Billion)
TABLE 5 U.S.dialysis center modality market estimates and forecast, by facility type 2017 - 2030 (USD Billion)
TABLE 6 U.S.dialysis center dialysis type market estimates and forecast, by region 2017 - 2030 (USD Billion)
LIST OF FIGURES
FIG. 1 U.S. dialysis centers market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Market outlook, 2022 (USD Billion)
FIG. 10 Penetration & growth prospect mapping
FIG. 11 Market trends & outlook
FIG. 12 Market driver relevance analysis (Current & future impact)
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 U.S. dialysis centers modality market share analysis, 2022 & 2030 (USD Billion)
FIG. 15 U.S. dialysis centers modality market: Segment dashboard
FIG. 16 In-center market, 2017 - 2030 (USD Billion)
FIG. 17 In-home market, 2017 - 2030 (USD Billion)
FIG. 18 SNF-based market, 2017 - 2030 (USD Billion)
FIG. 19 U.S. dialysis centers dialysis type market share analysis, 2022 & 2030 (USD Billion)
FIG. 20 U.S. dialysis centers dialysis type market: Segment dashboard
FIG. 21 Hemodialysis, 2017 - 2030 (USD Billion)
FIG. 22 Peritoneal dialysis, 2017 - 2030 (USD Billion)
FIG. 23 U.S. dialysis centers facility type market share analysis, 2022 & 2030 (USD Billion)
FIG. 24 U.S. dialysis centers facility type market: Segment dashboard
FIG. 25 Dialysis chains market, 2017 - 2030 (USD Billion)
FIG. 26 Independent facilities market, 2017 - 2030 (USD Billion)
FIG. 27 Hospital-based market, 2017 - 2030 (USD Billion)
FIG. 28 U.S. dialysis centers region market share analysis, 2022 & 2030 (USD Billion)
FIG. 29 U.S. dialysis centers region market: Segment dashboard
FIG. 30 Northeast market, 2017 - 2030 (USD Billion)
FIG. 31 Southeast market, 2017 - 2030 (USD Billion)
FIG. 32 Southwest market, 2017 - 2030 (USD Billion)
FIG. 33 Midwest market, 2017 - 2030 (USD Billion)
FIG. 34 West market, 2017 - 2030 (USD Billion)
FIG. 35 Recent development & impact analysis
FIG. 36 Competition categorization
FIG. 37 Company market position analysis
FIG. 1 U.S. dialysis centers market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Market outlook, 2022 (USD Billion)
FIG. 10 Penetration & growth prospect mapping
FIG. 11 Market trends & outlook
FIG. 12 Market driver relevance analysis (Current & future impact)
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 U.S. dialysis centers modality market share analysis, 2022 & 2030 (USD Billion)
FIG. 15 U.S. dialysis centers modality market: Segment dashboard
FIG. 16 In-center market, 2017 - 2030 (USD Billion)
FIG. 17 In-home market, 2017 - 2030 (USD Billion)
FIG. 18 SNF-based market, 2017 - 2030 (USD Billion)
FIG. 19 U.S. dialysis centers dialysis type market share analysis, 2022 & 2030 (USD Billion)
FIG. 20 U.S. dialysis centers dialysis type market: Segment dashboard
FIG. 21 Hemodialysis, 2017 - 2030 (USD Billion)
FIG. 22 Peritoneal dialysis, 2017 - 2030 (USD Billion)
FIG. 23 U.S. dialysis centers facility type market share analysis, 2022 & 2030 (USD Billion)
FIG. 24 U.S. dialysis centers facility type market: Segment dashboard
FIG. 25 Dialysis chains market, 2017 - 2030 (USD Billion)
FIG. 26 Independent facilities market, 2017 - 2030 (USD Billion)
FIG. 27 Hospital-based market, 2017 - 2030 (USD Billion)
FIG. 28 U.S. dialysis centers region market share analysis, 2022 & 2030 (USD Billion)
FIG. 29 U.S. dialysis centers region market: Segment dashboard
FIG. 30 Northeast market, 2017 - 2030 (USD Billion)
FIG. 31 Southeast market, 2017 - 2030 (USD Billion)
FIG. 32 Southwest market, 2017 - 2030 (USD Billion)
FIG. 33 Midwest market, 2017 - 2030 (USD Billion)
FIG. 34 West market, 2017 - 2030 (USD Billion)
FIG. 35 Recent development & impact analysis
FIG. 36 Competition categorization
FIG. 37 Company market position analysis
